Your browser doesn't support javascript.
Real-world evidence for improved outcomes with histamine antagonists and aspirin in 22,560 COVID-19 patients.
Mura, Cameron; Preissner, Saskia; Nahles, Susanne; Heiland, Max; Bourne, Philip E; Preissner, Robert.
  • Mura C; School of Data Science and Department of Biomedical Engineering, University of Virginia, Charlottesville, VA, USA. cmura@virginia.edu.
  • Preissner S; Department Oral and Maxillofacial Surgery, Charité-Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Berlin, Germany. Saskia.Preissner@charite.de.
  • Nahles S; Department Oral and Maxillofacial Surgery, Charité-Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Berlin, Germany.
  • Heiland M; Department Oral and Maxillofacial Surgery, Charité-Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Berlin, Germany.
  • Bourne PE; School of Data Science and Department of Biomedical Engineering, University of Virginia, Charlottesville, VA, USA.
  • Preissner R; Institute of Physiology and Science-IT, Charité-Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Berlin, Germany.
Signal Transduct Target Ther ; 6(1): 267, 2021 07 14.
Article in English | MEDLINE | ID: covidwho-1310792

Full text: Available Collection: International databases Database: MEDLINE Main subject: Aspirin / COVID-19 Limits: Humans Language: English Journal: Signal Transduct Target Ther Year: 2021 Document Type: Article Affiliation country: S41392-021-00689-y

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: Aspirin / COVID-19 Limits: Humans Language: English Journal: Signal Transduct Target Ther Year: 2021 Document Type: Article Affiliation country: S41392-021-00689-y